Alzamend Neuro, Inc. (ALZN)
2.02
+0.19
(+10.38%)
USD |
NASDAQ |
Feb 19, 16:00
1.93
-0.09
(-4.46%)
After-Hours: 04:15
Alzamend Neuro Market Cap : 7.679M for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Medpace Holdings, Inc. | 12.67B |
| Allogene Therapeutics, Inc. | 478.68M |
| Embecta Corp. | 623.59M |
| BrightSpring Health Services, Inc. | 7.358B |
| ACADIA Pharmaceuticals, Inc. | 4.116B |
Market Cap Related Metrics
| Price to Book Value | 1.756 |
| Price | 2.02 |
| Earnings Yield | -272.1% |